Marketdash
Back to Stock Market News

Five Stocks Making Moves Tuesday: Microchip Beats Guidance While Galapagos Exits Cell Therapy

MarketDash Editorial Team
2 days ago
U.S. stock futures are climbing Tuesday morning as investors eye earnings from AngioDynamics, AAR Corp, and Penguin Solutions. Microchip Technology raised its revenue outlook, while Galapagos announced plans to wind down its cell therapy operations.

With U.S. stock futures pointing higher Tuesday morning, several companies are positioning themselves for investor attention as earnings season continues and strategic shifts take shape.

Microchip Technology Inc (MCHP) delivered some welcome news to investors, announcing that it expects third-quarter fiscal 2026 net sales of approximately $1.185 billion. That's comfortably above its prior guidance range of $1.109 billion to $1.149 billion, suggesting demand trends are improving faster than the chipmaker initially anticipated. The semiconductor stock responded enthusiastically, climbing 3.2% to $69.20 in after-hours trading.

On the earnings front, AngioDynamics, Inc (ANGO) is expected to report before the opening bell Tuesday. Wall Street analysts are forecasting a quarterly loss of 10 cents per share on revenue of $76.30 million. The medical device company's shares slipped 0.2% to $13.20 in extended trading ahead of the report.

AAR Corp (AIR), which provides aviation services and products, is set to release earnings after the market close. Analysts are projecting quarterly earnings of $1.04 per share on revenue of $761.13 million. Shares edged up 0.8% to $88.70 in after-hours activity as investors await the results.

In a significant strategic pivot, Galapagos NV - ADR (GLPG) announced that its board has decided to initiate the winding down of the company's cell therapy activities following a comprehensive strategic review. The biotech company is apparently deciding to focus its resources elsewhere rather than continue investing in this particular therapeutic area. Investors seemed to approve of the clarity, sending shares up 6% to $34.70 in the after-hours session.

Finally, Penguin Solutions Inc. (PENG) is expected to post quarterly earnings of 44 cents per share on revenue of $338.76 million when it reports after the closing bell. The high-performance computing solutions provider saw its shares rise 0.6% to $21.19 in after-hours trading.

As these companies report results and strategic decisions, investors will be parsing the details for signals about broader industry trends and company-specific execution.

Back to Stock Market News

Five Stocks Making Moves Tuesday: Microchip Beats Guidance While Galapagos Exits Cell Therapy

MarketDash Editorial Team
2 days ago
U.S. stock futures are climbing Tuesday morning as investors eye earnings from AngioDynamics, AAR Corp, and Penguin Solutions. Microchip Technology raised its revenue outlook, while Galapagos announced plans to wind down its cell therapy operations.

With U.S. stock futures pointing higher Tuesday morning, several companies are positioning themselves for investor attention as earnings season continues and strategic shifts take shape.

Microchip Technology Inc (MCHP) delivered some welcome news to investors, announcing that it expects third-quarter fiscal 2026 net sales of approximately $1.185 billion. That's comfortably above its prior guidance range of $1.109 billion to $1.149 billion, suggesting demand trends are improving faster than the chipmaker initially anticipated. The semiconductor stock responded enthusiastically, climbing 3.2% to $69.20 in after-hours trading.

On the earnings front, AngioDynamics, Inc (ANGO) is expected to report before the opening bell Tuesday. Wall Street analysts are forecasting a quarterly loss of 10 cents per share on revenue of $76.30 million. The medical device company's shares slipped 0.2% to $13.20 in extended trading ahead of the report.

AAR Corp (AIR), which provides aviation services and products, is set to release earnings after the market close. Analysts are projecting quarterly earnings of $1.04 per share on revenue of $761.13 million. Shares edged up 0.8% to $88.70 in after-hours activity as investors await the results.

In a significant strategic pivot, Galapagos NV - ADR (GLPG) announced that its board has decided to initiate the winding down of the company's cell therapy activities following a comprehensive strategic review. The biotech company is apparently deciding to focus its resources elsewhere rather than continue investing in this particular therapeutic area. Investors seemed to approve of the clarity, sending shares up 6% to $34.70 in the after-hours session.

Finally, Penguin Solutions Inc. (PENG) is expected to post quarterly earnings of 44 cents per share on revenue of $338.76 million when it reports after the closing bell. The high-performance computing solutions provider saw its shares rise 0.6% to $21.19 in after-hours trading.

As these companies report results and strategic decisions, investors will be parsing the details for signals about broader industry trends and company-specific execution.